Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Heated Gloves May Improve Hand Function in Diffuse Systemic Sclerosis

Rosemarie Curley, MPT, DPT, & Jeananne Elkins, PT, PhD, DPT, MPH  |  Issue: October 2017  |  October 16, 2017

Systemic sclerosis (SSc), a subtype of scleroderma, is a rare, complex autoimmune disease characterized by widespread vasculopathy of the small arteries and fibroblast dysfunction.1,2 It has been described as a fibrosing micro­vascular disease, because vascular injury precedes and leads to tissue fibrosis.3 The resulting Raynaud’s phenomenon, pain, skin thickening and tightening, and multi-organ involvement have a significant impact on daily function.2-7

Two subtypes of SSc: limited and diffuse systemic sclerosis (dSSc). Both types involve Raynaud’s, gastrointestinal dysfunction and cutaneous fibrosis of the face, forearms, hands and fingers, but dSSc is the more severe of the two because it also affects the trunk, lower extremities and internal organs. Moreover, dSSc is progressive and has a 10-year survival rate of about 67%.8,9

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

A major impact on quality of life for individuals with dSSc is loss of hand function due to pain, Raynaud’s phenomenon, ulcers and acro-osteolysis.3,4,10,11 Caused by pathologic vasoconstriction of the small vessels of thermoregulation and exacerbated by stress and cold, Raynaud’s is usually the first clinical symptom of dSSc.3 It is a source of substantial pain and disability in dSSc.1,3,4,12,13

Figure 1

Figure 1
Manifestations of diffuse systemic sclerosis are visible in the hands: shortening of distal phalanges due to acro-osteolysis in bilateral thumbs (A–C), ring finger (B) and left middle finger compared with the right (D); thumbs fully flexed (C). Note color changes (A–D), overall shortening (B), digital pitting scars (arrows), swollen fingers and tight, shiny skin (A,D).

In addition, and often quite devastating to patients, ischemic digital ulcers (DUs) develop in more than 50% of patients with dSSc.14 DUs are extremely painful and often take weeks to heal.10,11,14‑16 They impair hand function, and to further complicate the disability, these ulcers frequently recur.4,17,18

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Another source of pain is acro-osteolysis, the resorption of the distal phalanges of the digits. Acro-osteolysis is associated with the vasculopathy and tissue hypoxia inherent in dSSc.5 This process results in overall shortening of the affected fingers. Loss of function is more pronounced when the index fingers and thumbs are involved.19

There is no cure for dSSc, but there are conservative treatment approaches and drug therapies to manage symptoms and to address internal organ involvement.7,14,20 Current evidence supports the use of vasodilators, such as amlodipine, to reduce vasospasms in Raynaud’s.3 Cyclophosphamide and azathioprine, both immunosuppressants, are often prescribed, yet have no direct benefit to hand function.7,20 Thus, it is important to adopt a patient-centered approach to the treatment of dSSc.

Page: 1 2 3 4 5 6 7 8 9 | Single Page
Share: 

Filed under:ConditionsOther Rheumatic ConditionsResearch Rheum Tagged with:Clinicaldrug therapyhand functionhand warmersheated glovesinterventionnon-pharmaceutical therapiesoutcomepatient careRaynaud’s phenomenonResearchrheumatologistSclerodermastudiesSystemic sclerosistissue fibrosisTreatmentvasculopathy

Related Articles

    Heated Gloves Provide Relief from Hand Pain, Dysfunction in Diffuse Systemic Sclerosis

    November 10, 2017

    Raynaud’s phenomenon in scleroderma or systemic sclerosis (SSc) is associated with significant discomfort and functional disability, especially in the presence of digital ulcers.1 Having lived with diffuse systemic sclerosis (dSSc) for nearly a decade, I can attest to this. It has been my experience that the hand pain and dysfunction in dSSc stems from Raynaud’s…

    Capillaroscopy a Safe and Direct Method for SSc Diagnosis

    June 13, 2011

    Seeing vessels clearly can help with discovery and timely treatment

    Rheumatologists Find Nailfold Capillaroscopy an Increasingly Useful Diagnostic Tool

    October 18, 2017

    Interest in viewing the nail capillaries dates to the late 17th century. Later research by Maurice Raynaud and others in the late 19th and early 20th century first established a direct link between the nailfold capillaries and certain medical conditions. Although underutilized in the past, with the advent of modern digital equipment and the validation…

    Diffuse Scleroderma: A 1991 Case Through the Lens of Today

    Diffuse Scleroderma: A 1991 Case Through the Lens of Today

    February 17, 2018

    The year was 1991. It was my first Tuesday as a rheumatology fellow at the University of Pittsburgh’s Presbyterian Hospital. Navigating a maze of buildings and hallways, I delivered myself to the entrance to the scleroderma clinic. Running late and not knowing whether there was a separate entrance for staff, I clicked open the door….

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences